| References |
| 1 |
Brown DD, Juhl RP, Warner SL "Decreased bioavailability of digoxin due to hypocholesterolemic interventions." Circulation 58 (1978): 164-72. [PMID: 647881]
|
| 2 |
Hall WH, Shappell SD, Doherty JE "Effect of cholestyramine on digoxin absorption and excretion in man." Am J Cardiol 39 (1977): 213-6. [PMID: 835478]
|
| 3 |
Marcus FI "Pharmacokinetic interactions between digoxin and other drugs." J Am Coll Cardiol 5 (1985): a82-90. [PMID: 2985676]
|
| 4 |
Product Information. Questran (cholestyramine). Par Pharmaceutical Inc, Chestnut Ridge, NY.
|
| 5 |
Rawashdeh NM, al-Hadidi HF, Irshaid YM, Battah AK "Gastrointestinal dialysis of digoxin using cholestyramine." Pharmacol Toxicol 72 (1993): 245-8. [PMID: 8372041]
|
| 6 |
Rodin SM, Johnson BF "Pharmacokinetic interactions with digoxin." Clin Pharmacokinet 15 (1988): 227-44. [PMID: 3056649]
|